Abstract
Prolonged treatment with a corticosteroid, unless to replace hormone deficiency, carries well recognised risks which include hypertension, hyperglycaemia, osteoporosis and cushingoid appearance. Moreover, doses above 5–7.5mg prednisolone daily can suppress the hypothalamo-pituitary-adrenal (HPA) axis. Needlessly high doses should therefore be avoided and treatment should be withdrawn when it is no longer needed. Many unwanted effects then disappear or cease to progress - though osteoporosis may persist and the child whose growth has been suppressed may not fully catch up. Disease relapse is the commonest difficulty during or following withdrawal of corticosteroid treatment. This article discusses some other problems that may arise.
Subject
Pharmacology (medical),General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Management of steroid reducing regimens by patients;International Journal of Pharmacy Practice;1993-07